Bevacizumab, sold under the trade name Avastin, is medication used to treat a number of types of cancers and a specific eye disease. For cancer it is given by slow injection into a vein and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. For age-related macular degeneration it is given by injection into the eye.

Bevacizumab was approved for medical use in the United States in 2004. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.... Wikipedia

 

 

 

Manufacturer's Website: Avastin                                                                                                                  Average retail cost: $783/dose

Search Terms: Avastin, Intravitreal Bevacizumab,  colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, age-related macular degeneration